Method for treating hematopoietic neoplasms
US9040500B2 · kind B2 · utility
1Cited by
38References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 2011 |
| Grant date | May 26, 2015 |
| Priority date | — |
| Expiry date | Nov 28, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to methods for treating a hematopoietic neoplasm comprising administering a therapeutically effective amount of a combretastatin compound, or a pharmaceutically acceptable salt thereof, to a subject having a hematological malignancy, wherein the combretastatin compound comprises a catechol or quinone moiety and is capable of forming a reactive oxygen species (ROS) in vivo. The method may further comprise co-administering a second chemotherapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.